Investigators focus on protein kinase D (PrKD) signaling in prostate cancer and the potential role of PrKD inhibitors therein and explore the possible clinical outcomes based on known function and expression of PrKD isoforms at different stages of prostate cancer.
[Journal Of Molecular Medicine]